For the quarter ending 2026-03-31, GNTX had $19,115,918 increase in cash & cash equivalents over the period. $120,041,067 in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income from consolidated operations | 98,421,059 | 93,270,878 | 100,886,704 | 190,524,495 |
| Depreciation and amortization | 25,656,252 | 25,232,797 | 25,928,524 | 52,880,443 |
| Gain on disposal of assets | 18,375 | 2,752,388 | 27,925 | 133,576 |
| Loss on disposal of assets | 7,524 | 12,520 | 12,452 | 791 |
| Gain on sale of investments and technology investment income | 1,090,014 | 1,715,576 | 805,777 | 832,046 |
| Loss on sale of investments and technology investment losses | 3,665,560 | 1,162,867 | 1,467,223 | 5,163,260 |
| Reserve for credit losses | 2,211,597 | 2,668,074 | 4,778,334 | - |
| Remeasurement of earnout provision | - | 2,623,277 | - | - |
| Deferred income taxes | -3,944,932 | -12,574,223 | -238,396 | -5,593,627 |
| Stock-based compensation expense related to employee stock options, employee stock purchases and restricted stock | 10,406,965 | 10,053,133 | 10,436,396 | 16,160,289 |
| Impairment charges - intangible assets | 2,800,000 | - | - | - |
| Impairment charges - investments | 2,739,466 | 5,705,808 | 2,194,148 | 6,182,000 |
| Impairment charges - goodwill and intangible assets | - | 0 | - | - |
| Accounts receivable, net | 50,951,356 | -16,156,271 | 9,875,241 | 20,896,565 |
| Inventories | 7,255,989 | 17,010,004 | 22,347,480 | -57,495,782 |
| Prepaid expenses and other | -5,958,594 | -6,615,293 | 9,165,685 | -2,765,009 |
| Accounts payable | 21,070,064 | -224,556 | 47,594,780 | 5,032,376 |
| Accrued liabilities, excluding dividends declared | 27,406,814 | -3,725,453 | -3,855,356 | 5,896,241 |
| Net cash provided by operating activities | 137,083,229 | 125,498,718 | 146,982,701 | 314,644,872 |
| Sales proceeds | 492,475 | 2,075,962 | 23,092,978 | 48,810,102 |
| Acquisition of businesses, net of cash acquired | - | 331 | 12,962,753 | 143,328,862 |
| Maturities and calls | - | 1,279,000 | 0 | 1,655,000 |
| Purchases | 3,145,703 | 9,752,549 | -1,064,443 | 17,331,563 |
| Voxx share purchases | - | 0 | - | - |
| Purchase of technology investments | - | 22,717,828 | - | - |
| Purchase of equity method investments | 5,491,789 | - | - | - |
| Plant and equipment additions | 17,042,162 | 25,669,941 | 35,584,615 | 67,834,222 |
| Proceeds from sale of plant and equipment | 70,262 | 8,148,809 | 14,006 | 245,105 |
| Loans to technology investment partners | 1,334,424 | 2,014,161 | 14,199,157 | - |
| Decrease (increase) in other assets | -877,306 | 963,563 | -2,648,393 | 3,573,774 |
| Net cash used for investing activities | -25,574,035 | -49,614,602 | -35,926,705 | -181,358,214 |
| Issuance of common stock from stock plan transactions | 2,103,787 | 1,122,149 | 7,054,310 | 6,283,742 |
| Cash dividends paid | 25,853,186 | 26,274,079 | 26,342,323 | 54,244,161 |
| Repurchases of common stock | 68,643,877 | 86,475,894 | 30,153,400 | 198,870,165 |
| Net cash used for financing activities | -92,393,276 | -111,627,824 | -49,441,413 | -246,830,584 |
| Net increase in cash, cash equivalents, and restricted cash | 19,115,918 | -35,743,708 | 61,614,583 | -113,543,926 |
| Cash and cash equivalents, beginning of period | 145,645,715 | 181,389,423 | 233,318,766 | - |
| Cash and cash equivalents, end of period | 164,761,633 | 145,645,715 | 181,389,423 | - |